Long-Term Experience With Kidney Transplantation From Hepatitis C-Positive Donors Into Hepatitis C-Positive Recipients
J.M. Morales(Hospital Universitario 12 De Octubre), Manuel Praga(Universidad Complutense de Madrid), Josep M. Campistol(Universitat de Barcelona), Federico Oppenheimer(Hospital Clínic de Barcelona), Giuseppe Castellano(University of Milan), Amado Andrés(Hospital Universitario 12 De Octubre), A Fuertes(Research Institute Hospital 12 de Octubre), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Miquel Bruguera(Hospital Clínic de Barcelona), Núria Esforzado(Hospital Clínic de Barcelona)
Cited by 103
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
|Kidney International|2014|506